These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 9218270
1. Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Stitzer ML, Walsh SL. Pharmacol Biochem Behav; 1997 Jul; 57(3):457-70. PubMed ID: 9218270 [Abstract] [Full Text] [Related]
6. Update on behavioral treatments for substance abuse. Childress A, Ehrman R, McLellan A, O'Brien C. NIDA Res Monogr; 1988 Oct 15; 90():183-92. PubMed ID: 3151925 [Abstract] [Full Text] [Related]
7. Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review. Tardelli VS, Lago MPPD, Mendez M, Bisaga A, Fidalgo TM. Behav Res Ther; 2018 Dec 15; 111():57-63. PubMed ID: 30316027 [Abstract] [Full Text] [Related]
8. Opiate and cocaine addictions: challenge for pharmacotherapies. Kreek MJ. Pharmacol Biochem Behav; 1997 Jul 15; 57(3):551-69. PubMed ID: 9218280 [Abstract] [Full Text] [Related]
9. Cellular responses to chronic treatment with drugs of abuse. Nestler EJ. Crit Rev Neurobiol; 1993 Jul 15; 7(1):23-39. PubMed ID: 8385579 [Abstract] [Full Text] [Related]
10. Pharmacotherapy of dual substance abuse and dependence. Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM. CNS Drugs; 2007 Jul 15; 21(3):213-37. PubMed ID: 17338593 [Abstract] [Full Text] [Related]
11. The use of pharmacogenetic techniques in drug abuse research. Marley RJ, Elmer GI, Goldberg SR. Pharmacol Ther; 1992 Jul 15; 53(2):217-37. PubMed ID: 1641407 [Abstract] [Full Text] [Related]
12. Achieving cocaine abstinence with a behavioral approach. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G. Am J Psychiatry; 1993 May 15; 150(5):763-9. PubMed ID: 8480823 [Abstract] [Full Text] [Related]
13. Pharmacologic management of relapse prevention in addictive disorders. Sofuoglu M, Kosten TR. Psychiatr Clin North Am; 2004 Dec 15; 27(4):627-48. PubMed ID: 15550284 [Abstract] [Full Text] [Related]
14. Contingency management for substance use disorders in Spain: Implications for research and practice. Secades-Villa R, García-Rodríguez O, Fernández-Hermida JR. Prev Med; 2015 Nov 15; 80():82-8. PubMed ID: 26164071 [Abstract] [Full Text] [Related]
15. Cocaine abuse among methadone maintenance patients: are there effective treatment strategies? Rawson RA, McCann MJ, Hasson AJ, Ling W. J Psychoactive Drugs; 1994 Nov 15; 26(2):129-36. PubMed ID: 7931857 [Abstract] [Full Text] [Related]
17. Recent advances in the psychotherapy of addictive disorders. Carroll KM. Curr Psychiatry Rep; 2005 Oct 15; 7(5):329-36. PubMed ID: 16216150 [Abstract] [Full Text] [Related]
18. Neurobiologic basis of nicotine addiction and psychostimulant abuse: a role for neurotensin? Fredrickson P, Boules M, Lin SC, Richelson E. Psychiatr Clin North Am; 2005 Sep 15; 28(3):737-51, 746. PubMed ID: 16122577 [Abstract] [Full Text] [Related]
19. Treating nicotine dependence. Glover ED, Glover PN. W V Med J; 2001 Sep 15; 97(1):39-43. PubMed ID: 11257836 [Abstract] [Full Text] [Related]
20. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research. Ritz MC, Kuhar MJ. Biochem Soc Symp; 1993 Sep 15; 59():51-64. PubMed ID: 7910741 [Abstract] [Full Text] [Related] Page: [Next] [New Search]